Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. 213357

   TESARO Bio Netherlands B.V.

   Ovarian Neoplasms

   phase 2 · small molecule · active

   1 trial →

2. 213403

   GlaxoSmithKline

   Lung Cancer, Non-Small Cell

   phase 2 · small molecule · active

   1 trial →

3. 213824

   GlaxoSmithKline

   Lung Cancer, Non-Small Cell

   phase 2 · small molecule · active

   1 trial →

4. 219590

   GlaxoSmithKline

   Neoplasms

   phase 2 · small molecule · active

   1 trial →

5. 2215-CL-0603

   Astellas Pharma GmbH

   FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

   phase 2 · small molecule · active

   1 trial →

6. 222730

   GlaxoSmithKline

   Ovarian Neoplasms

   phase 2 · other · active

   1 trial →

7. 222892

   GlaxoSmithKline

   MMRp/ MSS colon cancer

   phase 2 · small molecule · active

   1 trial →

8. 223050

   GlaxoSmithKline

   Neoplasms, Prostate

   phase 2 · other · active

   1 trial →

9. 223675

   GlaxoSmithKline

   Gastrointestinal Neoplasms

   phase 2 · other · active

   1 trial →

10. 224035

    GlaxoSmithKline

    Neoplasms, Colorectal

    phase 2 · other · active

    1 trial →

11. 225Ac-J591

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 · small molecule · active

    2 trials →

12. 225Ac-LNC1011

    The First People's Hospital of Lianyungang

    Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

13. 22752

    Bayer AG

    HER2 mutation, Advanced solid tumors

    phase 2 · small molecule · active

    1 trial →

14. 2X-121

    Allarity Therapeutics

    Advanced Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

15. 300148

    GlaxoSmithKline

    Neoplasms

    phase 2 · small molecule · active

    1 trial →

16. 3124001

    Orion Laboratories Pty.

    Metastatic castration-resistant prostate cancer.

    phase 2 · small molecule · active

    1 trial →

17. 3134003

    Orion Laboratories Pty.

    Neoplasms benign malignant and unspecified (incl. cysts and polyps)

    phase 2 · small molecule · active

    1 trial →

18. 42756493BLC2001

    Janssen-Cilag International N.V.

    Urothelial cancer

    phase 2 · small molecule · active

    1 trial →

19. 42756493BLC2002

    Janssen-Cilag International N.V.

    Metastatic or Locally Advanced Urothelial Cancer

    phase 2 · small molecule · active

    1 trial →

20. 42756493BLC2003

    Janssen-Cilag International N.V.

    Cohort 1 and 2: High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) with FGFR Mutations or Fusions Cohort 3 Intermediate Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) with FGFR Mutations or Fusions

    phase 2 · small molecule · active

    1 trial →

21. 42756493CAN2002

    Janssen-Cilag International N.V.

    Advanced solid tumors (other than Urothelial tumors), and FGFR gene alterations.

    phase 2 · small molecule · active

    1 trial →

22. 5-Fluorouracil

    Hospital Authority, Hong Kong

    Cancer (Advanced Stage)

    phase 2 · small molecule · active

    1 trial →

23. 5-Fluorouracil (5-FU)

    HALOZYME THERAPEUTICS, INC.

    Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma

    phase 2 · small molecule · completed

    1 trial →

24. 54179060CLL2032

    Janssen-Cilag International N.V.

    Untreated Chronic Lymphocytic Leukemia

    phase 2 · small molecule · active

    1 trial →

25. 54179060MCL3004

    Janssen-Cilag International N.V.

    Relapsed/Refractory Mantle Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

26. 54767414LEU2002

    Wuhan Createrna Science and Technology Co., Ltd

    Primary plasma cell leukemia

    phase 2 · small molecule · active

    1 trial →

27. 5541-CL-0201

    Astellas Pharma GmbH

    Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

28. 609A

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Sarcoma, Soft Tissue

    phase 2 · small molecule · active

    1 trial →

29. 61186372GIC2002

    Janssen-Cilag International N.V.

    Advanced or Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

30. 61186372HNC2002

    Janssen-Cilag International N.V.

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

31. 61186372NSC2002

    Janssen-Cilag International N.V.

    Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small Cell Lung Cancer.

    phase 2 · small molecule · active

    1 trial →

32. 61186372NSC2005

    Janssen-Cilag International N.V.

    EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

33. 61186372NSC2007

    Janssen-Cilag International N.V.

    EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

34. 61186372PANSC2001

    Janssen-Cilag International N.V.

    Unresectable Metastatic Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

35. 61186372PANSC2002

    Janssen-Cilag International N.V.

    Metastatic Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

36. 67-22 PREcoopERA

    Partner Therapeutics Limited

    ER-positive/HER2-negative early breast cancer

    phase 2 · small molecule · active

    1 trial →

37. 68Ga-DOTATATE and 68Ga-FAPI

    The First People's Hospital of Lianyungang

    Tumor Positron-Emission Tomography

    phase 2 · small molecule · completed

    1 trial →

38. 68Ga-Dotatoc

    Disc Medicine

    nasopharyngeal carcinoma

    phase 2 · small molecule · active

    1 trial →

39. 68Ga-FAP-CHX

    The First People's Hospital of Lianyungang

    Tumor

    phase 2 · small molecule · active

    1 trial →

40. 68Ga-FAPI-46

    Istituto Gentili S.r.l.

    oncological disease suspicion/ new diagnosis or with a previously treated tumour, with an inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: [18F]F-FDG PET/CT

    phase 2 · small molecule · active

    1 trial →

41. 68Ga-FAPI-46

    The George Institute

    Triple-negative breast cancer (TNBC) patients at high risk of relapse

    phase 2 · small molecule · active

    1 trial →

42. 68Ga-FAPI-46

    The George Institute

    Non-metastatic Pancreatic ductal adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

43. 68Ga-G21

    The First People's Hospital of Lianyungang

    Prostate Cancer (Adenocarcinoma)

    phase 2 · small molecule · active

    1 trial →

44. 68Ga-NODAGA-SNA006

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer

    phase 2 · small molecule · active

    1 trial →

45. 68Ga-NY104 PET/CT

    Peking University Third Hospital

    Clear Cell Renal Cell Carcinoma

    phase 2 · other · active

    1 trial →

46. 68Ga-NY104 PET/CT

    The First People's Hospital of Lianyungang

    Clear Cell Renal Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

47. 6QC-ICG, Placebo for 6QC-ICG

    Disc Medicine

    Breast cancer

    phase 2 · small molecule · active

    1 trial →

48. 8951-CL-0103

    Astellas Pharma GmbH

    Advanced cancer of the stomach or the gastroesophageal junction

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions